ARALEZ PHARMACEUTICALS INC.

Profile

Company Names

ARALEZ PHARMACEUTICALS INC.

Addresses

2800 PARK PLACE, 666 BURRARD STREET, VANCOUVER, A1 V6C 2Z7

Phone Numbers

919-913-1030

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2015

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$75,000,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2016-02-05 
$75,000,000.00 
$75,000,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ADRIAN 
 
ADAMS 
EXECUTIVE OFFICER, DIRECTOR
ARALEZ PHARMACEUTICALS INC.   |  IMPEL NEUROPHARMA INC   |  ACELRX PHARMACEUTICALS INC   |  TALPHERA, INC.
JENNIFER 
L. 
ARMSTRONG 
EXECUTIVE OFFICER
ARALEZ PHARMACEUTICALS INC.
JASON 
M. 
ARYEH 
DIRECTOR
ARALEZ PHARMACEUTICALS INC.
SCOTT 
J. 
CHARLES 
EXECUTIVE OFFICER
TRIBUTE PHARMACEUTICALS CANADA INC.   |  ARALEZ PHARMACEUTICALS INC.
NEAL 
F. 
FOWLER 
DIRECTOR
ARALEZ PHARMACEUTICALS INC.   |  LIQUIDIA TECHNOLOGIES INC
MARK 
A. 
GLICKMAN 
EXECUTIVE OFFICER
ARALEZ PHARMACEUTICALS INC.   |  NEUROBO PHARMACEUTICALS, INC.   |  METAVIA INC.
ROB 
 
HARRIS 
DIRECTOR
ARALEZ PHARMACEUTICALS INC.   |  CANNAROYALTY CORP.   |  ZENIGATA VENTURES, INC.
ARTHUR 
S. 
KIRSCH 
DIRECTOR
ARALEZ PHARMACEUTICALS INC.   |  LIQUIDIA TECHNOLOGIES INC
ANDREW 
I. 
KOVEN 
EXECUTIVE OFFICER
TRIBUTE PHARMACEUTICALS CANADA INC.   |  ARALEZ PHARMACEUTICALS INC.   |  KALA BIO, INC.
KENNETH 
B. 
LEE JR. 
DIRECTOR
ARALEZ PHARMACEUTICALS INC.
SETH 
A. 
RUDNICK, M.D. 
DIRECTOR
CHIMERIX INC   |  ARALEZ PHARMACEUTICALS INC.
F. MARTIN 
 
THRASHER 
DIRECTOR
ARALEZ PHARMACEUTICALS INC.
ERIC 
L. 
TRACHTENBERG 
EXECUTIVE OFFICER
ENOBIA PHARMA CORP   |  TRIBUTE PHARMACEUTICALS CANADA INC.   |  ARALEZ PHARMACEUTICALS INC.   |  KALA PHARMACEUTICALS, INC.
JAMES 
P. 
TURSI, M.D. 
EXECUTIVE OFFICER
ARALEZ PHARMACEUTICALS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-02-19
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
Debt 
2016-02-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#